Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxaliplatin-induced renal tubular vacuolization.
Joybari AY, Sarbaz S, Azadeh P, Mirafsharieh SA, Rahbari A, Farasatinasab M, Mokhtari M. Joybari AY, et al. Among authors: farasatinasab m. Ann Pharmacother. 2014 Jun;48(6):796-800. doi: 10.1177/1060028014526160. Epub 2014 Mar 10. Ann Pharmacother. 2014. PMID: 24615628
Paclitaxel-Induced Fingerprints Loss.
Azadeh P, Yaghobi Joybari A, Amini A, Farasatinasab M. Azadeh P, et al. Among authors: farasatinasab m. Ann Pharmacother. 2014 Sep;48(9):1249-1250. doi: 10.1177/1060028014539145. Epub 2014 Jun 13. Ann Pharmacother. 2014. PMID: 24928103 No abstract available.
Fingerprint changes among cancer patients treated with paclitaxel.
Azadeh P, Dashti-Khavidaki S, Joybari AY, Sarbaz S, Jafari A, Yaseri M, Amini A, Farasatinasab M. Azadeh P, et al. Among authors: farasatinasab m. J Cancer Res Clin Oncol. 2017 Apr;143(4):693-701. doi: 10.1007/s00432-016-2314-1. Epub 2016 Dec 17. J Cancer Res Clin Oncol. 2017. PMID: 27988843
Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: a double-blind, randomized, placebo-controlled study.
Mokhtari M, Farasatinasab M, Jafarpour Machian M, Yaseri M, Ghorbani M, Ramak Hashemi SM, Nikoobakht M, Golchin N, Mohammadi G, Sistanizad M. Mokhtari M, et al. Among authors: farasatinasab m. Eur J Clin Pharmacol. 2020 Apr;76(4):491-499. doi: 10.1007/s00228-019-02802-1. Epub 2020 Jan 3. Eur J Clin Pharmacol. 2020. PMID: 31900543 Clinical Trial.
Dabigatran as a Treatment Option for Heparin-Induced Thrombocytopenia.
Nasiripour S, Saif M, Farasatinasab M, Emami S, Amouzegar A, Basi A, Mokhtari M. Nasiripour S, et al. Among authors: farasatinasab m. J Clin Pharmacol. 2019 Jan;59(1):107-111. doi: 10.1002/jcph.1300. Epub 2018 Oct 4. J Clin Pharmacol. 2019. PMID: 30285276
29 results